Delivery Order SPE2DX22D0089-SPE2D825F2P55
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $47,608.56 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp is a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $13,677.48 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a child contract with no set-aside designation, competitively awarded through open procurement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,412.16 to AmerisourceBergen Drug Corp (CAGE: 0U9U0) on June 30, 2025, with an ultimate completion date of July 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The place of performance is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,954.56 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award issued to the prime contractor and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $47,477.79 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside delivery order was performed in Conshohocken, Pennsylvania, and represents a child action under a larger contract vehicle. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $29,247.48 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999.9 million through December 2026. The award was competitively...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $40,466.64 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor and represents procurement of medical supplies for defense healthcare operations. The work is to be performed at AmerisourceBergen's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $44,104.32 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was competitively awarded with no...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order valued at $1,640.16 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 13, 2025. This non-competitive, firm fixed-price delivery order is scheduled for ultimate completion on August 14, 2025, with performance taking place at the company's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,259.02 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 31, 2025, with an ultimate completion date of August 1, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military...
- SPE2DX22D0089Indefinite Delivery Contract
- SPE2DX22D0089-SPE2D825F2P55Delivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,840.50 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with ultimate completion by July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contractor's federal contract portfolio demonstrates extensive delivery of pharmaceuticals and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/28/25 |